CN101768128B - 一种含10%以上异构体的缬沙坦的精制方法 - Google Patents
一种含10%以上异构体的缬沙坦的精制方法 Download PDFInfo
- Publication number
- CN101768128B CN101768128B CN200910001859A CN200910001859A CN101768128B CN 101768128 B CN101768128 B CN 101768128B CN 200910001859 A CN200910001859 A CN 200910001859A CN 200910001859 A CN200910001859 A CN 200910001859A CN 101768128 B CN101768128 B CN 101768128B
- Authority
- CN
- China
- Prior art keywords
- butanone
- valsartan
- isomer
- refining
- type isomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910001859A CN101768128B (zh) | 2009-01-05 | 2009-01-05 | 一种含10%以上异构体的缬沙坦的精制方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910001859A CN101768128B (zh) | 2009-01-05 | 2009-01-05 | 一种含10%以上异构体的缬沙坦的精制方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101768128A CN101768128A (zh) | 2010-07-07 |
CN101768128B true CN101768128B (zh) | 2012-10-10 |
Family
ID=42501251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910001859A Active CN101768128B (zh) | 2009-01-05 | 2009-01-05 | 一种含10%以上异构体的缬沙坦的精制方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101768128B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130137737A1 (en) * | 2010-08-03 | 2013-05-30 | Novartis Ag | Highly crystalline valsartan |
CN102329276B (zh) * | 2011-09-30 | 2013-09-25 | 浙江新赛科药业有限公司 | 一种缬沙坦母液的回收方法 |
CN103435567B (zh) * | 2013-09-09 | 2015-08-26 | 山东新华制药股份有限公司 | 缬沙坦的精制方法 |
CN103819421A (zh) * | 2014-02-21 | 2014-05-28 | 浙江华海药业股份有限公司 | 一种含10%以上异构体缬沙坦的精制方法 |
CN104610185B (zh) * | 2014-03-10 | 2017-06-27 | 杭州领业医药科技有限公司 | 缬沙坦母液的回收方法 |
CN104030996B (zh) * | 2014-05-21 | 2016-06-01 | 丽珠医药集团股份有限公司 | 一种缬沙坦的合成方法 |
CN105859646A (zh) * | 2016-06-06 | 2016-08-17 | 浙江华海药业股份有限公司 | 一种缬沙坦的精制方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5965592A (en) * | 1990-02-19 | 1999-10-12 | Novartis Corporation | Acyl compounds |
-
2009
- 2009-01-05 CN CN200910001859A patent/CN101768128B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5965592A (en) * | 1990-02-19 | 1999-10-12 | Novartis Corporation | Acyl compounds |
Also Published As
Publication number | Publication date |
---|---|
CN101768128A (zh) | 2010-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101768128B (zh) | 一种含10%以上异构体的缬沙坦的精制方法 | |
DK2418195T3 (en) | Agomelatinhydrogenhalogenidkompleks and manufacturing method thereof | |
CN108503621B (zh) | 一种富马酸沃诺拉赞的制备方法 | |
US8686153B2 (en) | Lenalidomide salts | |
CN103613558A (zh) | 一种缬沙坦的制备方法 | |
WO2009062377A1 (fr) | Résolution de 4,5-diméthoxy-1-(méthylaminométhyl)-benzocyclobutane | |
CN102746231A (zh) | 塞来昔布制备工艺 | |
CN107698574B (zh) | 一种高纯度阿瑞匹坦的精制制备工艺 | |
US9815801B2 (en) | Method of refining valsartan comprising more than or equal to 10% D-isomers | |
CN108892670B (zh) | 一种高纯度替格瑞洛的制备方法 | |
TWI635076B (zh) | 吡咯衍生物之製造方法及其中間體 | |
CN103435567B (zh) | 缬沙坦的精制方法 | |
CN104829590B (zh) | 一种纯化曲格列汀的方法 | |
CN103554049A (zh) | 一种制备缬沙坦的方法 | |
CN105949184B (zh) | 一种盐酸阿罗洛尔的精制方法 | |
CN102190600A (zh) | 一种右旋西酞普兰中间体s-型二醇的制备方法 | |
CN102344392B (zh) | 一种蛋白脱乙酰酶抑制剂伏立诺他的精制方法 | |
CN110437083A (zh) | 重酒石酸间羟胺对映异构体的合成方法 | |
CN105330645A (zh) | 达比加群酯中间体的制备方法 | |
CN102250004B (zh) | 3-[(1-(1s)-苯乙基)氨基]-2,3,4,5-四氢-2-氧代-1h-(3s)-苯并氮杂卓的制备方法 | |
CN106188036B (zh) | 纯化化合物的方法 | |
CN109422702B (zh) | 赖诺普利中间体及其纯化方法 | |
KR100633232B1 (ko) | 신규한 6-[4-(1-시클로헥실-1h-테트라졸-5-일)부톡시]-3,4-디히드로-2(1h)-퀴놀리논 정제방법 | |
JP2006282668A (ja) | ロサルタンカリウム結晶形アルファ | |
CN104496921B (zh) | 一种缬沙坦粗品母液回收方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY Effective date: 20131125 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Shi Huilin Inventor after: Huang Xiangliang Inventor after: Chen Wei Inventor after: Wan Xiaoming Inventor after: Zhou Hu Inventor after: Tu Guoliang Inventor before: Huang Xiangliang Inventor before: Chen Wei Inventor before: Wan Xiaoming |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: HUANG XIANGLIANG CHEN WEI WAN XIAOMING TO: SHI HUILIN HUANG XIANGLIANG CHEN WEI WAN XIAOMING ZHOU HU TU GUOLIANG |
|
TR01 | Transfer of patent right |
Effective date of registration: 20131125 Address after: 317024 flood bridge, Linhai City, Zhejiang Patentee after: Zhejiang Huahai Pharmaceutical Co., Ltd. Patentee after: Shanghai Institute of pharmaceutical industry Address before: 317024 Development Zone of Linhai bridge, Linhai City, Zhejiang Patentee before: Zhejiang Huahai Pharmaceutical Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY Effective date: 20150616 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Huang Xiangliang Inventor after: Chen Wei Inventor after: Wan Xiaoming Inventor before: Shi Huilin Inventor before: Huang Xiangliang Inventor before: Chen Wei Inventor before: Wan Xiaoming Inventor before: Zhou Hu Inventor before: Tu Guoliang |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: SHI HUILIN HUANG XIANGLIANG CHEN WEI WAN XIAOMING ZHOU HU TU GUOLIANG TO: HUANG XIANGLIANG CHEN WEI WAN XIAOMING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150616 Address after: 317024 flood bridge, Linhai City, Zhejiang Patentee after: Zhejiang Huahai Pharmaceutical Co., Ltd. Address before: 317024 flood bridge, Linhai City, Zhejiang Patentee before: Zhejiang Huahai Pharmaceutical Co., Ltd. Patentee before: Shanghai Institute of pharmaceutical industry |